We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Mid-Cap ETFs Looking Good Amid Market Uncertainties
Read MoreHide Full Article
Wall Street has surprised with rallies despite rising Delta variant cases. Investors are however on the edge considering certain factors that might impact the current investing environment. Factors like surging Delta variant cases and the Federal Reserve meeting where it might announce plans to taper bond purchases are also raising worries. U.S. consumers also seem worried about the sustainability of economic recovery from the pandemic-led slump, rising Delta variant threat and increasing inflation levels.
Intensifying investors’ concerns further, September is historically considered the worst-performing month for Wall Street. Analysts expect a market correction in September. According to the LPL Financial data published in a Yahoo Finance article, the S&P 500 has fallen about 1%, on average, in September since 1950. Certain recent economic data releases also turned out to be very disappointing. The U.S. economy added only 235,000 jobs in August 2021 (the lowest in seven months).
Meanwhile, the FDA granting the first full U.S. approval to Pfizer (PFE)/BioNTech’s (BNTX) coronavirus vaccine, Comirnaty (BNT162b), has also boosted investors’ confidence. The full FDA approval is expected to increase the confidence for imposing vaccine mandates. Also, the unvaccinated population is now more likely to opt for vaccinations.
Considering the mixed sentiments, mid-cap funds are gaining increased attention as they provide both growth and stability in comparison to the small-cap and large-cap counterparts. As such, investors seeking to capitalize on the strong fundamentals but worried about uncertainty should consider mid-cap ETFs. Here, we have presented five popular mid-cap ETFs like Vanguard Mid-Cap ETF (VO - Free Report) , SPDR S&P MIDCAP 400 ETF Trust (MDY - Free Report) , iShares Russell Mid-Cap Value ETF (IWS - Free Report) , Vanguard Mid-Cap Growth ETF (VOT - Free Report) and Schwab U.S. Mid-Cap ETF (SCHM - Free Report) .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Mid-Cap ETFs Looking Good Amid Market Uncertainties
Wall Street has surprised with rallies despite rising Delta variant cases. Investors are however on the edge considering certain factors that might impact the current investing environment. Factors like surging Delta variant cases and the Federal Reserve meeting where it might announce plans to taper bond purchases are also raising worries. U.S. consumers also seem worried about the sustainability of economic recovery from the pandemic-led slump, rising Delta variant threat and increasing inflation levels.
Intensifying investors’ concerns further, September is historically considered the worst-performing month for Wall Street. Analysts expect a market correction in September. According to the LPL Financial data published in a Yahoo Finance article, the S&P 500 has fallen about 1%, on average, in September since 1950. Certain recent economic data releases also turned out to be very disappointing. The U.S. economy added only 235,000 jobs in August 2021 (the lowest in seven months).
Meanwhile, the FDA granting the first full U.S. approval to Pfizer (PFE)/BioNTech’s (BNTX) coronavirus vaccine, Comirnaty (BNT162b), has also boosted investors’ confidence. The full FDA approval is expected to increase the confidence for imposing vaccine mandates. Also, the unvaccinated population is now more likely to opt for vaccinations.
Considering the mixed sentiments, mid-cap funds are gaining increased attention as they provide both growth and stability in comparison to the small-cap and large-cap counterparts. As such, investors seeking to capitalize on the strong fundamentals but worried about uncertainty should consider mid-cap ETFs. Here, we have presented five popular mid-cap ETFs like Vanguard Mid-Cap ETF (VO - Free Report) , SPDR S&P MIDCAP 400 ETF Trust (MDY - Free Report) , iShares Russell Mid-Cap Value ETF (IWS - Free Report) , Vanguard Mid-Cap Growth ETF (VOT - Free Report) and Schwab U.S. Mid-Cap ETF (SCHM - Free Report) .